COVID-19 Vaccination Improved Psychological Distress (Anxiety and Depression Scores) in Chronic Kidney Disease Patients: A Prospective Study
Autor:
García Llana, Helena (1)
; Gandia, Lorena
; Orti, Marisa
; Gimenez-Civera, Elena
; Forquet, Claudia
; D'Marco, Luis
; Puchades, Maria Jesus
; Sargsyan, Mari
; Sanchis, Irina
; Ribera, Carmen
; Marco, Ma Ines
; Ferra, Cristela Moncho
; Perez-Baylach, Carmen Maria
; Bonilla, Begona
; Moncho Frances, Francesc
; Perez-Bernat, Elisa
; Sancho, Asuncion
; Gorriz, Jose Luis
Fecha:
2022Palabra clave:
Tipo de Ítem:
Articulo Revista IndexadaDirección web:
https://www.mdpi.com/2076-393X/10/2/299
Resumen:
The purpose of the study is to analyze the impact of vaccination against SARS-CoV-2 on anxiety and depression scores in patients with different modalities of chronic kidney disease. One hundred and seventeen renal patients (50 hemodialysis patients, 13 peritoneal dialysis patients, 32 kidney transplants, and 22 advanced chronic kidney disease patients at pre-dialysis care) were evaluated for depression, anxiety, health-related quality of life (HRQOL), and perceived fears and resources with standardized (Hospital Anxiety and Depression Scale (HADS)) and self-reported questionnaires. The measure points were before vaccination and 15 days after vaccination. The main finding of the study was that there was a decrease in the global mean of normal scores for anxiety and depression symptoms in chronic kidney disease patients post-vaccination. We did not find statistically significant differences in depression or anxiety scores, nor any HRQOL differences between the treatment groups. The three main fears reported by the participants at baseline were those of adverse effects, not getting the vaccine, and lack of information. These findings highlight the potential interest of assessing psychological variables related to the impact of vaccination against SARS-CoV-2. New studies will be required to assess the impact of comprehensive vaccine coverage and its psychological impact.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
19 |
3 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Effects of introducing rest intervals in functional fitness training
Hernández-Lougedo, Juan; Cimadevilla-Pola, Eduardo; Fernández-Rodríguez, Tomás; Guodemar-Pérez, Jesús; Otero-Campos, Álvaro; Lozano-Estevan, María Del Carmen; Cañuelo-Márquez, Ana María; de Jesús-Franco, Fernando (1); Garnacho-Castaño, Manuel V.; García-Fernández, Pablo; Maté-Muñoz, José Luis (MDPI, 2021)Background: Functional Fitness Training (FFT) is a new exercise modality prioritizing functional multi-joint movements executed at high intensity as a circuit. Objective: To examine the impacts of introducing rest intervals ... -
Gold Glyconanoparticles Combined with 91–99 Peptide of the Bacterial Toxin, Listeriolysin O, Are Efficient Immunotherapies in Experimental Bladder Tumors
Terán-Navarro, Hector; Zeoli, Andrea; Salines-Cuevas, David; Marradi, Marco; Montoya, Noemí (1); Gonzalez-Lopez, Elena; Ocejo-Vinyals, J. Gonzalo; Dominguez-Esteban, Mario; Gutierrez-Baños, Jose Luis; Campos-Juanatey, Felix; Yañez-Diaz, Sonsoles; Garcia-Castaño, Almudena; Rivera, Fernando; Duran, Ignacio; Álvarez-Domínguez, Carmen (1) (Cancers, 2022)This study presents proof of concept assays to validate gold nanoparticles loaded with the bacterial peptide 91–99 of the listeriolysin O toxin (GNP-LLO91–99 nanovaccines) as immunotherapy for bladder tumors. GNP-LLO91–99 ... -
The Polemic Diagnostic Role of TP53 Mutations in Liquid Biopsies from Breast, Colon and Lung Cancers
Garrido-Navas, M. Carmen (1); García-Díaz, Abel; Molina-Vallejo, María Pilar; González-Martínez, Coral; Alcaide Lucena, Miriam; Cañas-García, Inés; Bayarri, Clara; Delgado, Juan Ramón; González, Encarna; Lorente, José Antonio; Serrano, M. José (Cancers, 11/2020)Being minimally invasive and thus allowing repeated measures over time, liquid biopsies are taking over traditional solid biopsies in certain circumstances such as those for unreachable tumors, very early stages or treatment ...